CN108096398A - Treat the Chinese medicinal formulae of atherosclerotic occlusive disease - Google Patents
Treat the Chinese medicinal formulae of atherosclerotic occlusive disease Download PDFInfo
- Publication number
- CN108096398A CN108096398A CN201810051609.XA CN201810051609A CN108096398A CN 108096398 A CN108096398 A CN 108096398A CN 201810051609 A CN201810051609 A CN 201810051609A CN 108096398 A CN108096398 A CN 108096398A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicinal
- medicinal formulae
- treatment
- occlusive disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The effectively Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease, it belongs to technical field of traditional Chinese pharmacology.It is of the present invention treatment atherosclerotic occlusive disease Chinese medicinal formulae mainly be made of Galium verum, Radix Astragali, earthworm, the radix paeoniae rubrathe, rhizoma alismatis, scorpio, Fructus Liquidambaris, corydalis tuber, honey-fried licorice root, honeysuckle, parts by weight be respectively 200~400 parts Galium verum, 200~400 parts of Radix Astragali, 100~200 parts of earthworm, 100~200 parts of the radix paeoniae rubrathe, 100~200 parts of rhizoma alismatis, 100~200 parts of scorpio, 100~200 parts of Fructus Liquidambaris, 100~200 parts of corydalis tuber, 100~200 parts of honey-fried licorice root, 150~300 parts of honeysuckle.To limbs pain cure rate 60% after patient's use of the present invention, the cold cure rate 68.7% of limbs, extremity numbness cure rate 70%, Charcot's syndrome cure rate is 68.3%.
Description
Technical field
The invention belongs to technical field of traditional Chinese pharmacology;More particularly to a kind of Chinese medicinal formulae for treating atherosclerotic occlusive disease.
Background technology
China has begun to step into aging society, and there are about more than 300,000,000 by the old man of 60 years old or more.Atherosclerotic occlusive disease is
Generalized atherosclerosis is systemic artery inner membrance and its middle level in degeneration, Hypertrophic changes in the performance of limbs part
Become, as a result make artery wall thickening, stiff, fine song and follow the string, secondary thrombus is formed, and causes arterial lumen narrow, even
Block, limbs is made the disease of corresponding ischemia symptom occur.The development of lesion makes tissue ischemia progressively aggravate, symptom by
The limping of having a rest property evolves as suffering limb rest pain, and then causes limbs that ulcer or necrosis occurs.This disease is apt to occur in the elderly, Europe
Man of the U.S. is particularly common.
The cause of disease of arteriosclerosis obliterans is unclear, but the susceptible factor that epidemiological study is found includes glycosuria
Disease, smoking, hypertension, disorders of lipid metabolism, plasma fibrinogen rise etc..Diabetes be it is generally acknowledged it is most important be susceptible to suffer from because
Element, and pathological development is fast, is susceptible to extremity gangrene.Nicotine and other harmful components in tobacco can damage endangium,
Prostaglandin metabolism, lipid-metabolism are influenced, Blood denseness, platelet function, blood coagulation system function etc. is influenced, and easily promotes blood
Pipe is shunk, and induces the formation of arteriosclerosis obliterans.Research finds the collective effect of several susceptible factors, this disease can be made to fall ill
Chance increases, and the relative risk such as individually smoked is 2.3, and smoking rises to 3.3 plus the relative risk of diabetes, then adds
Upper hypertension relative risk is up to 6.3.
Arteriosclerosis obliterans men and women can occur, but common with male patient, generally fall ill after the middle age, be one
Kind geriatric disease, is often associated with diabetes, coronary heart disease, hypertension, cerebrovas-cularaccident etc..The entire course of disease can be divided into 4 clinics
Period.At present, the active drug for the treatment of atherosclerotic occlusive disease etc. is lacked both at home and abroad.Atherosclerotic occlusive disease incidence carries year by year
Extremity gangrene can occur when serious for height, and amputation rate and case fatality rate are all higher, and great prestige is brought to the existence of the elderly
The side of body, thus it is more and more in widespread attention.Such active drug of existing market circulation is few, thus is ground for this sick experiment
Study carefully and clinical research has very important significance.
The content of the invention
It is an object of the present invention to provide a kind of Chinese medicinal formulaes of effective treatment atherosclerotic occlusive disease.
The invention is realized by the following technical scheme:
A kind of Chinese medicinal formulae for treating atherosclerotic occlusive disease, the Chinese medicinal formulae master of the treatment atherosclerotic occlusive disease
It is if heavy by being made of Galium verum, Radix Astragali, earthworm, the radix paeoniae rubrathe, rhizoma alismatis, scorpio, Fructus Liquidambaris, corydalis tuber, honey-fried licorice root, honeysuckle
Amount number be respectively 200~400 parts Galium verum, 200~400 parts of Radix Astragali, 100~200 parts of earthworm, 100~200 parts
The radix paeoniae rubrathe, 100~200 parts of rhizoma alismatis, 100~200 parts of scorpio, 100~200 parts of Fructus Liquidambaris, 100~200 parts of corydalis tuber,
100~200 parts of honey-fried licorice root, 150~300 parts of honeysuckle.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease of the present invention, described treats in atherosclerotic occlusive disease
Prescription agent is made of the component of following parts by weight, 200 parts of Galium verum, 200 parts of Radix Astragali, 100 parts of earthworm, 100 parts of the radix paeoniae rubrathe, rhizoma alismatis
100 parts, 100 parts of scorpio, 100 parts of Fructus Liquidambaris, 100 parts of corydalis tuber, 100 parts of honey-fried licorice root, 150 parts of honeysuckle.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease of the present invention, described treats in atherosclerotic occlusive disease
Prescription agent is made of the component of following parts by weight, 400 parts of Galium verum, 400 parts of Radix Astragali, 200 parts of earthworm, 200 parts of the radix paeoniae rubrathe, rhizoma alismatis
200 parts, 200 parts of scorpio, 200 parts of Fructus Liquidambaris, 200 parts of corydalis tuber, 200 parts of honey-fried licorice root, 300 parts of honeysuckle.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease of the present invention, described treats in atherosclerotic occlusive disease
Prescription agent is made of the component of following parts by weight, 300 parts of Galium verum, 300 parts of Radix Astragali, 150 parts of earthworm, 150 parts of the radix paeoniae rubrathe, rhizoma alismatis
150 parts, 150 parts of scorpio, 150 parts of Fructus Liquidambaris, 150 parts of corydalis tuber, 150 parts of honey-fried licorice root, 200 parts of honeysuckle.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease of the present invention, described treats in atherosclerotic occlusive disease
Prescription agent is made of the component of following parts by weight, 310 parts of Galium verum, 310 parts of Radix Astragali, 160 parts of earthworm, 160 parts of the radix paeoniae rubrathe, rhizoma alismatis
160 parts, 160 parts of scorpio, 160 parts of Fructus Liquidambaris, 160 parts of corydalis tuber, 160 parts of honey-fried licorice root, 210 parts of honeysuckle.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease of the present invention, described treats in atherosclerotic occlusive disease
Prescription agent is made of the component of following parts by weight, 320 parts of Galium verum, 320 parts of Radix Astragali, 170 parts of earthworm, 170 parts of the radix paeoniae rubrathe, rhizoma alismatis
170 parts, 170 parts of scorpio, 170 parts of Fructus Liquidambaris, 170 parts of corydalis tuber, 170 parts of honey-fried licorice root, 240 parts of honeysuckle.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease of the present invention, described treats in atherosclerotic occlusive disease
Prescription agent is made of the component of following parts by weight, 360 parts of Galium verum, 360 parts of Radix Astragali, 180 parts of earthworm, 180 parts of the radix paeoniae rubrathe, rhizoma alismatis
180 parts, 180 parts of scorpio, 180 parts of Fructus Liquidambaris, 180 parts of corydalis tuber, 190 parts of honey-fried licorice root, 280 parts of honeysuckle.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease of the present invention, Galium verum all herbal medicine is pungent, bitter, trembles with fear.Heat-clearing
Removing toxic substances, promoting blood circulation and breaking stagnation, diuresis, promoting menstruation are antipruritic.For hepatitis, cough due to wind-heat evil, oedema, abscess of throat, paddy-field dermatitis, urticaria, malignant boil
Sore carbuncle swells, traumatic injury, fracture, women's vim and vigour pain, trichomoniasis, snake bite.Root:It is sweet, it trembles with fear.Clearing away heat to stop bleeding, promoting blood circulation.
For spitting blood, bleeding from five sense organs or subcutaneous tissue is had blood in stool, metrorrhagia, hematuria, irregular menstruation, abdominal pain, blood stasis and swelling pain, traumatic injury, dysentery etc..
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease of the present invention, Radix Astragali is perennial herb, 50-100 lis high
Rice.Main root is plump, wooden, normal branch, canescence.Stem is upright, and top multi-branched has thin rib, by white pubescence, originates in Inner Mongol
The ground such as Gu, Shanxi, Gansu, Heilungkiang.The medicinal history for having more than 2000 years so far of Radix Astragali, there is enhancing immunity of organism work(
Energy, liver protection, diuresis, anti-aging, resisting stress, decompression and wide antibacterial action.But the real evil Sheng of table, retention of dampness due to stagnation of QI, dyspepsia are stopped
It is stagnant, ulcer from the beginning of or heat toxin such as still contains at real examples and the hyperactivity of yang due to yin deficiency person after bursting, clothes must be prohibited.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease of the present invention is China's weight containing a variety of amino acid in earthworm
One of Chinese medicine wanted.Earliest Chinese pharmacology monograph《Sheng Nong's herbal classic》In just have earthworm in 67 kinds of animal drugs recording.《God
Agriculture book on Chinese herbal medicine warp》Low-grades are classified as, there is heat-clearing arresting convulsion, dredging collateral, relieving asthma, diuresis.High fever, coma are used for after normal frying, is shied
The diseases such as epilepsy twitch, joint pain, dyspnea and cough due to lung-heat, oliguria oedema, hypertension.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease of the present invention, the radix paeoniae rubrathe are the ranunculaceae plant radix paeoniae rubrathe or the river radix paeoniae rubrathe
Dry root, spring, the excavation of two season of autumn remove rhizome, fibrous root and silt, dry.Hardship is slightly cold.Return liver warp.There is clearing heat and cooling blood, it is living
The effect of blood and dissolving stasis.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease of the present invention, the perennial plant of Waterplantain, high 50-
100cm.Underground tuberosity, spherical, diameter is up to 4.5cm, crust brown, dense majority fibrous root.Major function Li Shui, excreting dampness,
It expels the heat-evil.Control difficult urination, oedema turgor, vomiting, rush down dysentery, phlegm and retained fluid, tinea pedis, gonorrhoea, hematuria.
It is of the present invention treatment atherosclerotic occlusive disease Chinese medicinal formulae preparation method, scorpio have " antispastic cramp and relieves dizziness,
Anti-inflammatory and attacked poison is removed obstruction in channels to relieve pain " function, it cures mainly " child convulsion, twitch spasm, skin disease, cardiovascular and cerebrovascular diseases, inflammation, hepatitis B, swollen
The diseases such as knurl ", the functions such as the preventing and curing diseases of scorpio food, strengthen immunity and anti-aging.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease of the present invention, Fructus Liquidambaris meridian distribution of property and flavor are hardship, are put down, Return liver,
Kidney channel has dispelling wind and eliminating dampness;It is soothing the liver active;The effect of Li Shui.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease of the present invention, corydalis tuber is Chinese tradition medicinal material, main to produce
In Zhejiang and Jiangsu, stem tuber is spherical in shape;Petal aubergine, summer-flowering;Capsule is cylindrical, and both ends are gradually narrow.Its stem tuber contains corydalis
A variety of alkaloids such as alkali, Biflorine through pulvis or fluid-acet-extract etc. is made, cure mainly all pains of trusted subordinate's waist and knee, irregular menstruation, disease
Lump in the abdomen, metrorrhagia, postpartum anemic fainting, lochiorrhagia, traumatic injury etc. have analgesia, calmness, syngignoscism.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease of the present invention, honey-fried licorice root is the Radix Glycyrrhizae baked with honey, is commonly called as
Process, exactly honey is put, middle honey is smelt in pot, used slow boiling instead and licorice piece is added to stir uniformly, 3~5min takes the dish out of the pot, put barn or
60~C of baking oven takes out when being dried to tack-free, cools.Honey-fried licorice root is similar round or oval section, surface rufous or ash
Brown, micro- glossy, section yellow to buff, cambium ring is apparent, ray irradiation shape.Zhigancao decoction has benefiting qi and nourishing yin,
Activate yang multiple arteries and veins therapeutic efficiency.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease of the present invention, honeysuckle is cold in nature, sweet in flavor, enters lung, the heart, stomach
Through having effects that clearing heat and detoxicating, anti-inflammatory, qi-restoratives treats wind, curing mainly disease under turgor, warm disease heating, the diseases such as heat toxin large carbuncle and tumour.
Its for dizziness, thirst, sweating and boring, enteritis, bacillary dysentery, measles, pneumonia, encephalitis, epidemic meningitis, acute mastitis, lose
The illnesss such as mass formed by blood stasis, appendicitis, skin infection, ulcer boils, erysipelas, parotitis, suppurative tonsillitis have certain curative effect.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease of the present invention, Galium verum is monarch, toil and cold in nature, Xin Zeneng
Row can dissipate, and have the work(of promoting blood circulation detumescence, and bitter cold then has the benefits of clearing heat, detoxicating, dispelling dampness, and medicine only has promoting blood circulation, dampness removing, solution simply
Malicious triple effect, therefore think monarch.Minister is with Radix Astragali, honeysuckle with dissolving stasis blood, and with clearing away damp-heat, compatibility monarch drug in a prescription is then invigorated blood circulation dispels clearing heat, detoxicating, dispelling dampness
The benefits of stasis of blood, more writes, and being aided with property walks the Fructus Liquidambaris altered with the stasis blocking for channels of dispelling, and helps with the work(of the radix paeoniae rubrathe, rhizoma alismatis promoting blood circulation and detoxication dampness removing,
Corydalis tuber, scorpio increase promoting blood circulation effect, and for Radix Glycyrrhizae to make, coordinating the drug actions of a prescription plays promoting blood circulation and removing obstruction in channels, the work(of clearing heat and detoxicating clearing damp altogether.
It is of the present invention treatment atherosclerotic occlusive disease Chinese medicinal formulae, have it is promoting blood circulation and removing obstruction in channels, clearing heat and detoxicating clearing damp
Effect.It is adapted to the surroundings artery such as atherosclerotic occlusive disease, Buerger's disease, aorto-arteritis, arterial embolism system
System disease.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease of the present invention, it is efficient to limbs pain after patient's use
53.1%, limbs cold efficient 60.9%, extremity numbness effective percentage 61.4%, efficient Charcot's syndrome is 66.8%.
Specific embodiment
Specific embodiment one:
A kind of Chinese medicinal formulae for treating atherosclerotic occlusive disease, the Chinese medicinal formulae of described treatment atherosclerotic occlusive disease by
The component of following parts by weight is made, 400 parts of Galium verum, 400 parts of Radix Astragali, 200 parts of earthworm, 200 parts of the radix paeoniae rubrathe, 200 parts of rhizoma alismatis, scorpio
200 parts, 200 parts of Fructus Liquidambaris, 200 parts of corydalis tuber, 200 parts of honey-fried licorice root, 300 parts of honeysuckle.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease described in present embodiment, it is effective to limbs pain after patient's use
Rate 55.4%, limbs cold efficient 67.7%, extremity numbness effective percentage 70%, efficient Charcot's syndrome is 68.3%.
Specific embodiment two:
A kind of Chinese medicinal formulae for treating atherosclerotic occlusive disease, the Chinese medicinal formulae of described treatment atherosclerotic occlusive disease by
The component of following parts by weight is made, 300 parts of Galium verum, 300 parts of Radix Astragali, 150 parts of earthworm, 150 parts of the radix paeoniae rubrathe, 150 parts of rhizoma alismatis, scorpio
150 parts, 150 parts of Fructus Liquidambaris, 150 parts of corydalis tuber, 150 parts of honey-fried licorice root, 200 parts of honeysuckle.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease described in present embodiment, randomly selects 200 artery sclerosis and closes
Disease patient is filled in, male patient 110, female patient 90, patient age is between 45~70, patient's average age 62 years old, disease
History 3 months~5 years, average medical history 2.45, patient take the Chinese medicine of the treatment atherosclerotic occlusive disease described in present embodiment
Prescription, 3 times a day, 3 months duration, the symptomatic condition for then counting patient is as shown in table 2:
2 pretherapy and post-treatment symptom contrast table of table
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease described in present embodiment, it is effective to limbs pain after patient's use
Rate 60%, limbs cold efficient 67.7%, extremity numbness effective percentage 64.9%, efficient Charcot's syndrome is 73.6%.
Specific embodiment three:
A kind of Chinese medicinal formulae for treating atherosclerotic occlusive disease, the Chinese medicinal formulae of described treatment atherosclerotic occlusive disease by
The component of following parts by weight is made, 400 parts of Galium verum, 400 parts of Radix Astragali, 200 parts of earthworm, 200 parts of the radix paeoniae rubrathe, 200 parts of rhizoma alismatis, scorpio
200 parts, 200 parts of Fructus Liquidambaris, 200 parts of corydalis tuber, 200 parts of honey-fried licorice root, 300 parts of honeysuckle.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease described in present embodiment, it is effective to limbs pain after patient's use
Rate 46%, limbs cold efficient 55.6%, extremity numbness effective percentage 60.3%, efficient Charcot's syndrome is 66.5%.
Specific embodiment four:
A kind of Chinese medicinal formulae for treating atherosclerotic occlusive disease, the Chinese medicinal formulae of described treatment atherosclerotic occlusive disease by
The component of following parts by weight is made, 300 parts of Galium verum, 300 parts of Radix Astragali, 150 parts of earthworm, 150 parts of the radix paeoniae rubrathe, 150 parts of rhizoma alismatis, scorpio
150 parts, 150 parts of Fructus Liquidambaris, 150 parts of corydalis tuber, 150 parts of honey-fried licorice root, 200 parts of honeysuckle.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease described in present embodiment, it is effective to limbs pain after patient's use
Rate 58.2%, limbs cold efficient 58.6%, extremity numbness effective percentage 57.4%, efficient Charcot's syndrome is 68.2%.
Specific embodiment five:
A kind of Chinese medicinal formulae for treating atherosclerotic occlusive disease, the Chinese medicinal formulae of described treatment atherosclerotic occlusive disease by
The component of following parts by weight is made, 310 parts of Galium verum, 310 parts of Radix Astragali, 160 parts of earthworm, 160 parts of the radix paeoniae rubrathe, 160 parts of rhizoma alismatis, scorpio
160 parts, 160 parts of Fructus Liquidambaris, 160 parts of corydalis tuber, 160 parts of honey-fried licorice root, 210 parts of honeysuckle.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease described in present embodiment, it is effective to limbs pain after patient's use
Rate 51%, limbs cold efficient 54.9%, extremity numbness effective percentage 60.4%, efficient Charcot's syndrome is 68.1%.
Specific embodiment six:
A kind of Chinese medicinal formulae for treating atherosclerotic occlusive disease, the Chinese medicinal formulae of described treatment atherosclerotic occlusive disease by
The component of following parts by weight is made, 320 parts of Galium verum, 320 parts of Radix Astragali, 170 parts of earthworm, 170 parts of the radix paeoniae rubrathe, 170 parts of rhizoma alismatis, scorpio
170 parts, 170 parts of Fructus Liquidambaris, 170 parts of corydalis tuber, 170 parts of honey-fried licorice root, 240 parts of honeysuckle.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease described in present embodiment, it is effective to limbs pain after patient's use
Rate 52.8%, limbs cold efficient 60.3%, extremity numbness effective percentage 56.4%, efficient Charcot's syndrome is 64.4%.
Specific embodiment seven:
A kind of Chinese medicinal formulae for treating atherosclerotic occlusive disease, the Chinese medicinal formulae of described treatment atherosclerotic occlusive disease by
The component of following parts by weight is made, 360 parts of Galium verum, 360 parts of Radix Astragali, 180 parts of earthworm, 180 parts of the radix paeoniae rubrathe, 180 parts of rhizoma alismatis, scorpio
180 parts, 180 parts of Fructus Liquidambaris, 180 parts of corydalis tuber, 190 parts of honey-fried licorice root, 280 parts of honeysuckle.
The Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease described in present embodiment, it is effective to limbs pain after patient's use
Rate 48.5%, limbs cold efficient 62.1%, extremity numbness effective percentage 60.8%, efficient Charcot's syndrome is 58.8%.
Claims (7)
1. a kind of Chinese medicinal formulae for treating atherosclerotic occlusive disease, it is characterised in that:The treatment atherosclerotic occlusive disease
Chinese medicinal formulae is mainly by by Galium verum, Radix Astragali, earthworm, the radix paeoniae rubrathe, rhizoma alismatis, scorpio, Fructus Liquidambaris, corydalis tuber, honey-fried licorice root, honeysuckle
Be made, parts by weight be respectively 200~400 parts Galium verum, 200~400 parts of Radix Astragali, 100~200 parts of earthworm, 100
~200 parts of the radix paeoniae rubrathe, 100~200 parts of rhizoma alismatis, 100~200 parts of scorpio, 100~200 parts of Fructus Liquidambaris, 100~200 parts
Corydalis tuber, 100~200 parts of honey-fried licorice root, 150~300 parts of honeysuckle.
2. the Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease according to claim 1, it is characterised in that:The treatment is moved
Arteries and veins hardening obliterans Chinese medicinal formulae be made of the component of following parts by weight, 200 parts of Galium verum, 200 parts of Radix Astragali, 100 parts of earthworm,
100 parts of the radix paeoniae rubrathe, 100 parts of rhizoma alismatis, 100 parts of scorpio, 100 parts of Fructus Liquidambaris, 100 parts of corydalis tuber, 100 parts of honey-fried licorice root, honeysuckle 150
Part.
3. the Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease according to claim 1, it is characterised in that:The treatment is moved
Arteries and veins hardening obliterans Chinese medicinal formulae be made of the component of following parts by weight, 400 parts of Galium verum, 400 parts of Radix Astragali, 200 parts of earthworm,
200 parts of the radix paeoniae rubrathe, 200 parts of rhizoma alismatis, 200 parts of scorpio, 200 parts of Fructus Liquidambaris, 200 parts of corydalis tuber, 200 parts of honey-fried licorice root, honeysuckle 300
Part.
4. the Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease according to claim 1, it is characterised in that:The treatment is moved
Arteries and veins hardening obliterans Chinese medicinal formulae be made of the component of following parts by weight, 300 parts of Galium verum, 300 parts of Radix Astragali, 150 parts of earthworm,
150 parts of the radix paeoniae rubrathe, 150 parts of rhizoma alismatis, 150 parts of scorpio, 150 parts of Fructus Liquidambaris, 150 parts of corydalis tuber, 150 parts of honey-fried licorice root, honeysuckle 200
Part.
5. the Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease according to claim 1, it is characterised in that:The treatment is moved
Arteries and veins hardening obliterans Chinese medicinal formulae be made of the component of following parts by weight, 310 parts of Galium verum, 310 parts of Radix Astragali, 160 parts of earthworm,
160 parts of the radix paeoniae rubrathe, 160 parts of rhizoma alismatis, 160 parts of scorpio, 160 parts of Fructus Liquidambaris, 160 parts of corydalis tuber, 160 parts of honey-fried licorice root, honeysuckle 210
Part.
6. the Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease according to claim 1, it is characterised in that:The treatment is moved
Arteries and veins hardening obliterans Chinese medicinal formulae be made of the component of following parts by weight, 320 parts of Galium verum, 320 parts of Radix Astragali, 170 parts of earthworm,
170 parts of the radix paeoniae rubrathe, 170 parts of rhizoma alismatis, 170 parts of scorpio, 170 parts of Fructus Liquidambaris, 170 parts of corydalis tuber, 170 parts of honey-fried licorice root, honeysuckle 240
Part.
7. the Chinese medicinal formulae for the treatment of atherosclerotic occlusive disease according to claim 1, it is characterised in that:The treatment is moved
Arteries and veins hardening obliterans Chinese medicinal formulae be made of the component of following parts by weight, 360 parts of Galium verum, 360 parts of Radix Astragali, 180 parts of earthworm,
180 parts of the radix paeoniae rubrathe, 180 parts of rhizoma alismatis, 180 parts of scorpio, 180 parts of Fructus Liquidambaris, 180 parts of corydalis tuber, 190 parts of honey-fried licorice root, honeysuckle 280
Part.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810051609.XA CN108096398A (en) | 2018-01-18 | 2018-01-18 | Treat the Chinese medicinal formulae of atherosclerotic occlusive disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810051609.XA CN108096398A (en) | 2018-01-18 | 2018-01-18 | Treat the Chinese medicinal formulae of atherosclerotic occlusive disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108096398A true CN108096398A (en) | 2018-06-01 |
Family
ID=62219194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810051609.XA Pending CN108096398A (en) | 2018-01-18 | 2018-01-18 | Treat the Chinese medicinal formulae of atherosclerotic occlusive disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108096398A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114569662A (en) * | 2022-03-08 | 2022-06-03 | 赵钢 | Preparation method of soft capsule for treating arteriosclerosis |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2088254C1 (en) * | 1994-10-04 | 1997-08-27 | Василий Николаевич Дармограй | Medicinal species for treatment and prophylaxis of vessel diseases |
CN104491776A (en) * | 2014-12-03 | 2015-04-08 | 陈啸 | Tradtional Chinese medicine preparation for treating chronic limb arteriosclerosis obliterans and preparation method thereof |
-
2018
- 2018-01-18 CN CN201810051609.XA patent/CN108096398A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2088254C1 (en) * | 1994-10-04 | 1997-08-27 | Василий Николаевич Дармограй | Medicinal species for treatment and prophylaxis of vessel diseases |
CN104491776A (en) * | 2014-12-03 | 2015-04-08 | 陈啸 | Tradtional Chinese medicine preparation for treating chronic limb arteriosclerosis obliterans and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
吕勃川 等: "康脉软胶囊治疗动脉硬化闭塞症的临床观察", 《中医药学报》 * |
赵钢 等: "康脉软胶囊治疗动脉硬化闭塞症的临床观察", 《中华中医药学会周围血管病分会第六届学术大会论文集》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114569662A (en) * | 2022-03-08 | 2022-06-03 | 赵钢 | Preparation method of soft capsule for treating arteriosclerosis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102048894B (en) | Traditional Chinese medicine composition for treating burn and preparation method thereof | |
CN104435449A (en) | Pharmaceutical composition for resisting atherosclerosis and application of pharmaceutical composition | |
CN108096398A (en) | Treat the Chinese medicinal formulae of atherosclerotic occlusive disease | |
CN105582421A (en) | Pharmaceutical composition for treating hemorrhoid | |
CN103055257B (en) | Traditional Chinese medicine for treating chronic gastritis and preparation method thereof | |
CN102370852A (en) | Chinese herbal medicine for treating chronic colitis | |
CN104800538A (en) | Traditional Chinese medicine for treating lung cancer | |
CN104771579A (en) | Traditional Chinese medicine formula for treating thyroid tumor | |
CN1296076C (en) | Medicine for clearing skin toxin | |
CN105561098A (en) | Medicine for treating erosive beriberi | |
CN104800302A (en) | Externally applied plaster for treating thromboangiitis obliterans and preparation method | |
CN104623532A (en) | Traditional Chinese medicine composition for treating glioma and preparation method thereof | |
CN104274706A (en) | Traditional Chinese medicine mixture for treating radioactive stomatitis | |
CN103933408A (en) | Traditional Chinese medicinal decoction for treating acute gouty arthritis | |
CN102641445A (en) | Medicine for treating dysentery and preparing method thereof | |
CN103316297B (en) | Traditional Chinese medicine for treating atrophic rhinitis | |
CN106344838A (en) | Chinese medicinal composition for treating oral ulcer | |
CN104922596A (en) | Traditional Chinese medicine composition for treating lithangiuria and preparation method thereof | |
CN105031109A (en) | Traditional Chinese medicine for treating lung cancer | |
CN105079487A (en) | Traditional Chinese medicine composition for treating heat stranguria | |
CN105055784A (en) | Traditional Chinese medicine for treating breast cancer | |
CN105106405A (en) | Traditional Chinese medicine for treating allergic eczema | |
CN104398731A (en) | Traditional Chinese medicament for treating chronic hepatitis | |
CN104666468A (en) | Pharmaceutical composition for treating hyperthyroidism and scrofula | |
CN104189433A (en) | Traditional Chinese medicine preparation for chronic appendicitis and preparation method of traditional Chinese medicine preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180601 |